Browse Related Topics:

2026 CVSL Reimbursement Updates for Boston Scientific Technologies

Published on: February 26, 2026

Description

Stay ahead of the 2026 Centers for Medicare & Medicaid Services (CMS) Final Rule changes with a fast, focused update designed for cardiovascular service line (CVSL) clinical, administrative and financial leaders. In this session, you'll get clear guidance on the documentation, coding and reimbursement shifts that matter most for high impact cardiovascular procedures, leveraging Boston Scientific’s key technologies:
• AGENT™ Drug Coated Balloon
• WATCHMAN™ LAAC Device
• FARAPULSE™ Pulsed Field Ablation System

Download the Slides

 

Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.